Tactive Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$253K Buy
2,666
+90
+3% +$8.54K 0.13% 110
2023
Q4
$230K Buy
+2,576
New +$230K 0.15% 81